This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Ecole Normale Superieure De Lyon, National Institute of Health and Medical Research. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2023
Title: Thierry Defrance: Innovator in Antibody Engineering
Introduction
Thierry Defrance is a notable inventor based in Lyon, France. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for antibody expression.
Latest Patents
Thierry Defrance holds a patent for a "Lentiviral vector expressing membrane-anchored or secreted antibody." This invention involves a multicistronic nucleic acid that enables the co-expression of sequences encoding both the light and heavy chains of an antibody. The patent outlines a complex structure that includes various coding sequences and splice sites, facilitating the production of separate proteins from a single nucleic acid construct. He has 1 patent to his name.
Career Highlights
Throughout his career, Thierry has worked with prestigious institutions such as University Claude Bernard - Lyon 1 and École Normale Supérieure de Lyon. His work has focused on advancing the understanding and application of lentiviral vectors in antibody engineering.
Collaborations
Thierry has collaborated with notable colleagues, including François-Loïc Cosset and Floriane Fusil. Their joint efforts have contributed to the advancement of research in the field of immunology.
Conclusion
Thierry Defrance's innovative work in antibody engineering showcases his commitment to advancing biotechnology. His contributions are significant in the ongoing development of therapeutic antibodies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile